| dc.creator |
US National Cancer Institute |
|
| dc.date |
2005-08-11T15:31:23Z |
|
| dc.date |
2005-08-11T15:31:23Z |
|
| dc.date |
2003-02-01 |
|
| dc.date |
2005-08-11T15:31:23Z |
|
| dc.date.accessioned |
2022-05-25T02:24:32Z |
|
| dc.date.available |
2022-05-25T02:24:32Z |
|
| dc.identifier |
NSC32743 |
|
| dc.identifier |
http://www.dspace.cam.ac.uk/handle/1810/35978 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/147915 |
|
| dc.format |
8732 bytes |
|
| dc.format |
7780 bytes |
|
| dc.format |
chemical/x-cml |
|
| dc.format |
chemical/x-cml |
|
| dc.language |
en_GB |
|
| dc.publisher |
Unilever Center for Molecular Informatics, Cambridge University |
|
| dc.title |
NSC32743 |
|
| dc.title |
Acetoxycycloheximide |
|
| dc.title |
Acetyloxycycloheximide |
|
| dc.title |
Antibiotic from Streptomyces albulus |
|
| dc.title |
AXM |
|
| dc.title |
Cycloheximide, acetoxy- |
|
| dc.title |
CYCLOHEXIMIDE, 4-ACETOXY-(E-B) |
|
| dc.title |
E 73 |
|
| dc.title |
Glutarimide, 3-[2-(5-acetoxy-3, 5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]- |
|
| dc.title |
Glutarimide, 3-[2-hydroxy-2-(5-hydroxy-3,5-dimethyl-2-oxocyclohexyl)ethyl]-, 5-acetate (8CI) |
|
| dc.title |
Glutarimide, 3-[2-hydroxy-2-(5-hydroxy-3, 5-dimethyl-2-oxocyclohexyl)ethyl]-, 5-acetate (8CI) |
|
| dc.title |
NSC-32743 |
|
| dc.title |
2, 6-Piperidinedione, 4-[2-[5-(acetyloxy)-3, 5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.alpha.(S*), 3.alpha.,5.alpha.]]- (9CI) |
|
| dc.title |
2,6-Piperidinedione, 4-[2-[5-(acetyloxy)-3, 5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.alpha.(S*), 3.beta.,5.beta.]]- |
|
| dc.title |
2,6-Piperidinedione, 4-[2-[5-(acetyloxy)-3, 5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.alpha.(S*), 3.alpha.,5.alpha.]]- (9CI) |
|
| dc.title |
2,6-Piperidinedione, 4-[2-[5-(acetyloxy)-3, 5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-, [1S-[1.alpha.(S*), 3.beta.,5.beta.]]- |
|
| dc.title |
4-Acetoxycycloheximide |
|
| dc.type |
Chemical Structures |
|